Anúncio
Anúncio

ENTX

ENTX logo

Entera Bio Ltd. Ordinary Shares

1.59
USD
Patrocinado
-0.18
-9.94%
06 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

1.61

+0.02
+1.32%

Relatórios de Lucros ENTX

Rácio de surpresa positiva

ENTX separação 21 de 28 últimas estimativas.

75%

Próximo Relatório

Data do Próximo Relatório
26 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.09
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
+28.57%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
+50.00%

Entera Bio Ltd. Ordinary Shares earnings per share and revenue

On 14 de nov. de 2025, ENTX reported earnings of -0.07 USD per share (EPS) for Q3 25, beating the estimate of -0.09 USD, resulting in a 23.75% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a -1.11% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.09 USD, with revenue projected to reach -- USD, implying an aumentar of 28.57% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
For Q3 2025, Entera Bio Ltd. Ordinary Shares reported EPS of -$0.07, beating estimates by 23.75%, and revenue of --, -- -- expectations.
The stock price moved down -1.11%, changed from $2.71 before the earnings release to $2.68 the day after.
The next earning report is scheduled for 26 de mar. de 2026.
Based on 3 analistas, Entera Bio Ltd. Ordinary Shares is expected to report EPS of -$0.09 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio